COVID-19

BBK Worldwide survey reveals patients want trial innovation

22-Oct-2020 By Jenni Spinner

The latest iteration of BBK Worldwide's Study Voices survey reveals thoughts on decentralized studies, telehealth and other trial technology.

BARDA enlists Current Health in COVID-19 monitoring

22-Oct-2020 By Jenni Spinner

The collaboration will target signs of early deterioration in patients, and predict infection severity to let caregivers know when to escalate care.

NIH kicks off COVID-19 immune modulator trial

21-Oct-2020 By Jenni Spinner

The US agency has launched a large clinical trial to examine the viability of using immune modulators to treat patients hospitalized with COVID-19.

COVID-19 response makes NZ an appealing trial destination

20-Oct-2020 By Jenni Spinner

A leader from a New Zealand-based CRO talks about the country’s handling of the pandemic, and how their low rates are making sponsors take notice.

FHI Clinical, Oracle partner on cloud-based trial tech

19-Oct-2020 By Jenni Spinner

The CRO and life-sciences tech firm collaborated on a solution capable of meeting challenges tied to starting and conducting global clinical trials.

CPhI Festival of Pharma

CPhI Pharma Awards recognize industry achievements

19-Oct-2020 By Jenni Spinner

The 17th annual awards program, announced during the CPhI Festival of Pharma virtual event, hails professionals from various aspects of the industry.

WHO: remdesivir shows little effect on COVID-19

19-Oct-2020 By Jenni Spinner

The agency’s Solidarity Therapeutics Trial examined a range of drugs repurposed for COVID-19 treatment, finding nearly no effect on patient mortality.

Novartis shines spotlight on patients living with MS

15-Oct-2020 By Jenni Spinner

The pharmaceutical firm’s More to uS is a UK-centered campaign that shares stories of people living (and thriving) after a multiple sclerosis diagnosis.

Current FDA COVID-19 advice and actions

14-Oct-2020 By Jenni Spinner

The federal government continues to offer life-sciences professionals advice and resources as they pursue treatments to help fight the COVID-19 virus.

Gilead signs remdesivir agreement with European Commission

13-Oct-2020 By Jenni Spinner

Under the terms of the contract, Gilead will supply the EC with up to half a million treatment courses of Veklury to treat COVID-19 patients.

hyperCORE names new CEO

13-Oct-2020 By Jenni Spinner

The clinical research site network has tapped 22-year industry veteran Karri Venn, president of research with LMC Manna, to lead the organization.

First COVID-19 patient treated in Noxopharm study

13-Oct-2020 By Jenni Spinner

The clinical-stage drug development company has kicked off testing the experimental anticancer drug Veyonda on severe patients in a Phase I trial.

Clinical trial volume, variety drive data solutions

08-Oct-2020 By Jenni Spinner

eClinical Solutions, a provider of clinical data service solutions, has seen an increase in interest in clinical data platform and other digital products.